Europe • Euronext Paris • EPA:SAN • FR0000120578
Overall SAN gets a fundamental rating of 5 out of 10. We evaluated SAN against 55 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of SAN while its profitability can be described as average. SAN has a decent growth rate and is not valued too expensively. SAN also has an excellent dividend rating.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROIC | 13.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.42 | ||
| Fwd PE | 9.51 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.35% |
ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
SANOFI (SAN.PA) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 11.42 and the Price/Book (PB) ratio is 2.65.
The financial health rating of SANOFI (SAN.PA) is 3 / 10.